Zdrowie i gospodarka · 24/03/1998
FDA Amends Animal Drug Regulations for Monensin
The FDA is removing duplicate assay limits for monensin from its animal drug regulations to ensure accuracy and consistency, a necessary step to maintain regulatory clarity.
Source: Federal Register — Food and Drug AdministrationOpen original release →